Estimation of the serial interval of pertussis in Dutch households

Epidemics

Volumn 7, Issue , 2014, Pages 1-6

  te Beest, Dennis E ^a   Henderson, Donna ^b   van der Maas, Nicoline A T ^a   de Greeff, Sabine C ^a   Wallinga, Jacco ^a   Mooi, Frits R ^a   Van Boven, Michiel ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Expectation Maximization; Household transmission; Maternal vaccination; Pertussis; Serial interval

Indexed keywords

ADULT; ARTICLE; BACTERIAL TRANSMISSION; BORDETELLA PERTUSSIS; FATHER; FEMALE; HOUSEHOLD; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MOTHER; NETHERLANDS; NONHUMAN; PERTUSSIS; PRIORITY JOURNAL; SIBLING; ANTIBIOTIC PROPHYLAXIS; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE TRANSMISSION; DUTCHMAN; INCUBATION TIME; INFECTION CONTROL; INFECTION PREVENTION; SOCIAL DISTANCE; AGE; BIOLOGICAL MODEL; BLOOD; CHEMOPROPHYLAXIS; ECONOMICS; FAMILY HEALTH; HETEROZYGOTE; INCIDENCE; MICROBIOLOGY; PREGNANCY; PREGNANT WOMAN; PREVENTION AND CONTROL; PREVENTIVE HEALTH SERVICE; PROCEDURES; STANDARDS; STATISTICS AND NUMERICAL DATA; TRANSMISSION; VERTICAL TRANSMISSION; WHOOPING COUGH;

PERTUSSIS VACCINE;

ADULT; AGE FACTORS; CARRIER STATE; CHEMOPREVENTION; FAMILY HEALTH; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INFANT; INFECTIOUS DISEASE INCUBATION PERIOD; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MODELS, BIOLOGICAL; MOTHERS; NETHERLANDS; PERTUSSIS VACCINE; PREGNANCY; PREGNANT WOMEN; WHOOPING COUGH;

EID: 84896120427     PISSN: 17554365     EISSN: 18780067     Source Type: Journal    
DOI: 10.1016/j.epidem.2014.02.001     Document Type: Article

References (35)

1. Altunaiji S., Kukuruzovic R., Curtis N., Massie J. Antibiotics for whooping cough (pertussis). Cochrane Database Syst. Rev. 2005, CD004404.
2. Anderson R.M., May R.M. Infectious Disease of Humans: Dynamics and Control 1992, Oxford University Press, Oxford.
3. Burnham K.P., Anderson D.R. Model Selection and Multimodel Inference: A Practical Information-theoretic Approach 1998, Springer, New York.
4. Castagnini L.A., Healy C.M., Rench M.A., Wootton S.H., Munoz F.M., Baker C.J. Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection. Clin. Infect. Dis. 2012, 54:78-84.
5. Cauchemez S., Ferguson N.M. Methods to infer transmission risk factors in complex outbreak data. J. R. Soc. Interface 2012, 9:456-469.
6. Cherry J.D. Epidemic pertussis in 2012 - the resurgence of a vaccine-preventable disease. N. Engl. J. Med. 2012, 367:785-787.
7. de Greeff S.C., de Melker H.E., van Gageldonk P.G.M., Schellekens J.F.P., van der Klis F.R.M., et al. Seroprevalence of pertussis in the Netherlands: evidence for increased circulation of Bordetela pertussis. PLoS ONE 2010, 5:e14183.
8. de Greeff S.C., Mooi F.R., Westerhof A., Verbakel J.M., Peeters M.F., Heuvelman C.J., Notermans D.W., Elvers L.H., Schellekens J.F., de Melker H.E. Pertussis disease burden in the household: how to protect young infants. Clin. Infect. Dis. 2010, 50:1339-1345.
9. de Greef S.C., Westerhof A., de Melker H.E., Mooi F.R., van Boven M. Household transmission of pertussis to newborns and the impact of maternal vaccination. Epidemiology 2012, 23:852-860.
10. De Serres G., Boulianne N., Duval B. Field effectiveness of erythromycin prophylaxis to prevent pertussis within families. Pediatr. Infect. Dis. J. 1995, 14:969-975.
11. De Serres G., Shadmani R., Duval B., Boulianne N., Dery P., Douville Fradet M., et al. Morbidity of pertussis in adolescents and adults. J. Infect. Dis. 2000, 182:174-179.
12. Fine P.E. The interval between successive cases of an infectious disease. Am. J. Epidemiol. 2003, 158:1039-1047.
13. Fraser C., Riley S., Anderson R.M., Ferguson N.M. Factors that make an infectious disease outbreak controllable. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:6146-6151.
14. Grant C.C., Reid S. Pertussis continues to put New Zealand's immunisation strategy to the test. N. Z. Med. J. 2010, 123:46-61.
15. Granstrom G., Sterner G., Nord C.E., Granstrom M. Use of erythromycin to prevent pertussis in newborns of mothers with pertussis. J. Infect. Dis. 1987, 155:1210-1214.
16. Guris D., Strebel P.M., Bardenheier B., Brennan M., Tachdjian R., Finch E., et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin. Infect. Dis. 1999, 28:1230-1237.
17. Halperin S.A., Bortolussi R., Langley J.M., Eastwood B.J., De Serres G. A randomized, placebo-controlled trial of erythromycin estolate chemoprophylaxis for household contacts of children with culture-positive bordetella pertussis infection. Pediatrics 1999, 104:e42.
18. Hens N., Calatayud L., Kurkela S., Tamme T., Wallinga J. Robust reconstruction and analysis of outbreak data: influenza A(H1N1)v transmission in a school-based population. Am. J. Epidemiol. 2012, 176:196-203.
19. Kenah E., Lipsitch M., Robins J.M. Generation interval and epidemic data analysis. Math. Biosci. 2008, 213:71-79.
20. Kenah E. Contact intervals, survival analysis of epidemic data, and estimation of R(0). Biostatistics 2011, 12:548-566.
21. Kuehn B.M. Panel backs wider pertussis vaccination to curb outbreaks, prevent deaths. JAMA 2010, 304:2684-2686.
22. Leuridan E., Hens N., Peeters N., de Witte L., Van der Meeren O., Van Damme P. Effect of a prepregnancy pertussis booster dose on maternal antibody titers in young infants. Pediatr. Infect. Dis. J. 2011, 30:608-610.
23. McCullagh P., Nelder J.A. Generalized Linear Models 1989, Chapman & Hall, London.
24. Mooi F.R., de Greeff S.C. The case for maternal vaccination against pertussis. Lancet Infect. Dis. 2007, 7:614-624.
25. Svensson Å. A note on generation times in epidemic models. Math. Biosci. 2007, 208:300-311.
26. te Beest D.E., et al. Estimating the generation interval of influenza A(H1N1) in a range of social settings. Epidemiology 2013, 24:244-250.
27. Teunis P.T., Heijne J., Sukhrie F., van Eijkeren J., Koopmans M., Kretzschmar M. Infectious disease transmission as a forensic problem: who infected whom. J. R. Soc. Interface 2013, 10:e20120955.
28. van Boven M., de Melker H.E., Schellekens J.F., Kretzschmar M. Waning immunity and sub-clinical infection in an epidemic model: implications for pertussis in The Netherlands. Math. Biosci. 2000, 164:161-182.
29. Vink, M.A., Bootsma, M.C.J., Wallinga, J., 2013. The serial intervals of respiratory infectious diseases: a literature review and systematic analysis (submitted for publication).
30. Vynnycky E., White R.G. An Introduction to Infectious Disease Modelling 2010, Oxford University Press, Oxford.
31. Wallinga J., Teunis P. Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures. Am. J. Epidemiol. 2004, 160:509-516.
32. Wallinga J., Lipsitch M. How generation intervals shape the relationship between growth rates and reproductive numbers. Proc. Biol. Sci. 2007, 274:599-604.
33. Wendelboe A.M., Van Rie A., Salmaso S., Englund J.A. Duration of immunity against pertussis after natural infection or vaccination. Pediatr. Infect. Dis. J. 2005, 24:S58-S61.
34. Ypma R.J., Bataille A.M., Stegeman A., Koch G., Wallinga J., van Ballegooijen W.M. Unravelling transmission trees of infectious diseases by combining genetic and epidemiological data. Proc. Biol. Sci. 2012, 279:444-450.
35. Ypma R.J., Jonges M., Bataille A., Stegeman A., Koch G., van Boven M., Koopmans M., van Ballegooijen W.M., Wallinga J. Genetic data provide evidence for wind-mediated transmission of highly pathogenic avian influenza. J. Infect. Dis. 2013, 207:730-735.